Exsudative AMD: Regression analysis of transpupillary thermotherapy with and without intravitreal injection of triamcinolone, bevacizumab and ranibizumab;Exsudative AMD: Regressionsanalyse von transpupillarer Thermotherapie mit und ohne intravitrealer Injektion von Triamcinolon sowie Bevacizumab und Ranibizumab

Klinische Monatsblatter fur Augenheilkunde

Volumn 227, Issue 11, 2010, Pages 897-904

  Weber, U ^a  

^a KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

anti VEGF therapies; bevacizumab; ranibizumab; Retina; triamcinolone; TTT

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; TRIAMCINOLONE;

ARTICLE; EXUDATIVE RETINA MACULA AGE RELATED DEGENERATION; EYE EXAMINATION; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; THERAPY EFFECT; TRANSPUPILLARY THERMOTHERAPY; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD; VISUAL FIELD DEFECT;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; RETROSPECTIVE STUDIES; TRIAMCINOLONE; VISUAL FIELDS;

EID: 78349297588     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1245370     Document Type: Article

References (20)

1. Agurto-Rivera R, Diaz-Rubio J, Torres-Bernal L et al. Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635]. BMC Ophthalmol 2005 5 27
2. Bashshur Z F., Haddad Z A., Schakal A R. et al. Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: the second year of a prospective study. Am J Ophthalmol 2009 148 (1) 59-65
3. Fahrmeir L, Künstler R, Pigrot I et al. Statistik. Berlin Heidelberg Springer-Verlag 2007
4. Ip M S., Scott I U., Brown G C. et al. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology 2008 115 (10) 1837-1846
5. Iu L P., Kwok A K. An update of treatment options for neovascular age-related macular degeneration. Hong Kong Med J 2007 13 (6) 460-470 Comment in: Hong Kong Med J 2008;14 (1): 81
6. Kourlas H, Schiller D S. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review. Clin Ther 2006 28 (1) 36-44
7. Lalwani G A., Rosenfeld P J., Fung A E. et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 2009 148 (1) 1-3
8. Lommatzsch A, Heimes B, Gutfleisch M et al. Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments. Eye 2009 [Epub ahead of print]
9. Maberley D A., Chew H, Ma P et al. Comparison of photodynamic therapy and transpupillary thermotherapy for subfoveal choroidal neovascularization due to age-related macular degeneration. Can J Ophthalmol 2005 40 (3) 378-383
10. Myint K, Armbrecht A M., Mon S et al. Transpupillary thermotherapy for the treatment of occult CNV in age-related macular degeneration: a prospective randomized controlled pilot study. Acta Ophthalmol Scand 2006 84 (3) 328-332
11. Nüesch E, Trelle S, Reichenbach S et al. Ausschluss von Patienten aus der Analyse: Auswirkung auf die Ergebnisse randomisierter kontrollierter Studien. Dt Aerzteblatt 2009 39 B1623-B1628
12. Schmidt K, Haverkamp R. Allgemeine Biometrie. www.msl.uni-bonn.de/../ biometrie10.pdf
13. Shah A R., Del Priore L V. Progressive visual loss in subfoveal exsudation in age-related macular degeneration: A metaanalysis using Lineweaver-Burke plots. Am J Ophthalmol 2007 143 83-89
14. Shah A R., Del Priore L V. Natural history of predominantly classic, minimally classi, and occult subgroups in exsudative age-related macular degeneration. Ophthalmology 2009 116 1901-1907
15. Stolba U, Krebs I, Lamar P D. et al. Long term results after transpupillary thermotherapy in eyes with occult choroidal neovascularisation associated with age related macular degeneration: a prospective trial. Br J Ophthalmol 2006 90 (2) 158-161
16. Subramanian M L., Ness S, Abedi G et al. Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial. Am J Ophthalmol 2009 148 875-882
17. Takeda A L., Colquitt J, Clegg A J. et al. Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review. Br J Ophthalmol 2007 91 (9) 1177-1182
18. Tranos P, Peter N M., Nath R et al. Visual function following transpupillary thermotherapy with adjusted laser parameters for the treatment of exudative age-related macular degeneration: a pilot study. Clin Experiment Ophthalmol 2006 34 (3) 226-232
19. Weber U, Hecker H. Transpupillare Thermotherapie bei occulten subretinalen Neovaskularisationen. Ophthalmologe 2005 102 355-362
20. Zhang X, Zhu X, Wang D et al. Low-power transpupillary thermotherapy combined with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization. Ophthalmic Res 2007 39 (4) 241-242